iBio
IBIO
$1.99
Share price
-1.97%
Change (1 day)
82.57%
Change (1 year)
Categories
iBio (IBIO) - Total debt
Total debt on the balance sheet as of December 2023 : $16.46 M
According to iBio's latest financial reports the company's total debt is $16.46 M. A company’s total debt is the sum of all current and non-current debts.
iBio - Total debt on balance sheet (from 2016 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-06-30 | $17.07 M | -33.73% |
| 2022-06-30 | $25.76 M | -21.26% |
| 2021-06-30 | $32.72 M | -0.57% |
| 2020-06-30 | $32.9 M | 32.25% |
| 2019-06-30 | $24.88 M | -0.79% |
| 2018-06-30 | $25.08 M | -0.73% |
| 2017-06-30 | $25.26 M | -0.67% |
| 2016-06-30 | $25.43 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 178,004.32% | 🇺🇸 USA |
 Genocea Biosciences
GNCA | $15.48 M | -5.97% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | $0.11 B | 615.14% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.86 B | 5,123.15% | 🇺🇸 USA |